APhA appoints Ilisa Bernstein Interim CEO
Dr. Bernstein will tap into her decades of leadership and strategy experience as she transitions into this new role at APhA
Dr. Bernstein will tap into her decades of leadership and strategy experience as she transitions into this new role at APhA
Active pharmaceutical ingredients revenue for the quarter was at Rs 913 crore
Susanne Kaestner joins the company as Senior Vice President, Quality and member of the Executive Team, and Dr. Thea Boehm as Vice President, Business Development.
PharmaLytica Expo to aid in chalking out pharma industry’s $130 Billion growth story by 2030
Follows Zealand Pharma’s appointment of Adam Steensberg as CEO and decision to refocus strategy
The proposed demerger is the most significant corporate change for GSK in the last 20 years
Companies concluded memorandum of understanding that Takeda will continue to provide distribution support for the Moderna COVID-19 vaccines for a transitional period
Dupixent would be the first and only medicine specifically indicated to treat prurigo nodularis in the U.S., if approved
Avillion announces expansion of partnership with AstraZeneca on PT027 and will fund and execute a new Phase 3b study
Subscribe To Our Newsletter & Stay Updated